UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.649

Sortiert nach

EZH2 inhibitors sensitize myeloma cell lines to panobinostat resulting in unique combinatorial transcriptomic changes

Oncotarget, 2018-04, Vol.9 (31), p.21930-21942

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum EZH2 protein levels are decreased in people with multiple sclerosis: A pilot study

Human Gene, 2024-05, Vol.40, Article 201278

2024

Link zum Volltext

Verfügbarkeit prüfen

AML-137: Expression of Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Gene (EZH2) In Acute Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S282-S283

2021

Link zum Volltext

Verfügbarkeit prüfen

AML-192: Enhancer of Zeste Homolog 2 (EZH2) in COVID-19-Positive Acute Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S289-S290

2021

Link zum Volltext

Verfügbarkeit prüfen

LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII

Oncotarget, 2017-07, Vol.8 (29), p.47565-47573

2017

Link zum Volltext

Verfügbarkeit prüfen

EZH2 Promotes Glioma Cell Proliferation, Invasion, and Migration via Mir-142-3p/KCNQ1OT1/HMGB3 Axis : Running Title: EZH2 Promotes Glioma cell Malignant Behaviors

Molecular neurobiology, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

USP7 inhibits TIMP2 by up-regulating the expression of EZH2 to activate the NF-κB/PD-L1 axis to promote the development of cervical cancer

Cellular signalling, 2022-08, Vol.96, p.110351-110351, Article 110351

2022

Link zum Volltext

Verfügbarkeit prüfen

EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer

Biomedicine & pharmacotherapy, 2024-06, Vol.175, p.116624-116624, Article 116624

2024

Link zum Volltext

Verfügbarkeit prüfen

Attenuated Salmonella-delivered PD-1 siRNA enhances the antitumor effects of EZH2 inhibitors in colorectal cancer

International immunopharmacology, 2023-11, Vol.124, p.110918-110918, Article 110918

2023

Link zum Volltext

Verfügbarkeit prüfen

Cross-species analyses unravel the complexity of H3K27me3 and H4K20me3 in the context of neural stem progenitor cells

Neuroepigenetics, 2016-06, Vol.6, p.10-25

2016

Link zum Volltext

Verfügbarkeit prüfen

2,2- dimethylbenzopyran derivatives containing pyridone structural fragments as selective dual-targeting inhibitors of HIF-1α and EZH2 for the treatment of lung cancer

Bioorganic chemistry, 2024-04, Vol.147, p.107419-107419, Article 107419

2024

Link zum Volltext

Verfügbarkeit prüfen

EZH2: a novel target for cancer treatment

Journal of hematology and oncology, 2020-07, Vol.13 (1), p.104-12, Article 104

2020

Link zum Volltext

Verfügbarkeit prüfen

The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells

Oncotarget, 2017-11, Vol.8 (58), p.98348-98359

2017

Link zum Volltext

Verfügbarkeit prüfen

Novel insights of EZH2-mediated epigenetic modifications in degenerative musculoskeletal diseases

Ageing research reviews, 2023-09, Vol.90, p.102034-102034, Article 102034

2023

Link zum Volltext

Verfügbarkeit prüfen

Telomere dysfunction alters intestinal stem cell dynamics to promote cancer

Developmental cell, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter

Oncotarget, 2018-03, Vol.9 (21), p.15512-15525

2018

Link zum Volltext

Verfügbarkeit prüfen

Enhancer of Zeste Homolog 2 Inhibition Induces HLA Class I Re-Expression in Merkel Cell Carcinoma

Journal of investigative dermatology, 2023-12, p.S0022-202X(23)03121-4

2023

Link zum Volltext

Verfügbarkeit prüfen

ABCL-211: Mutations at Codon 641 of Exon 16 of EZH2 in Circulating and Tumor DNA: A Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with the R-CHOP Regimen

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S382-S382

2021

Link zum Volltext

Verfügbarkeit prüfen

EZH2-mediated development of therapeutic resistance in cancer

Cancer letters, 2024-04, Vol.586, p.216706-216706, Article 216706

2024

Link zum Volltext

Verfügbarkeit prüfen

RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer

Oncotarget, 2015-02, Vol.6 (4), p.2263-2276

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification and functional analysis of the hub Ferroptosis-Related gene EZH2 in diabetic kidney disease

International immunopharmacology, 2024-05, Vol.133, p.112138-112138, Article 112138

2024

Link zum Volltext

Verfügbarkeit prüfen

Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498

Gene, 2019-12, Vol.720, p.144099-144099, Article 144099

2019

Link zum Volltext

Verfügbarkeit prüfen

EZH2 in normal and malignant hematopoiesis

Leukemia, 2014-01, Vol.28 (1), p.44-49

2014

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of EZH2 attenuates inhibitory synaptic transmission via the pro-inflammatory pathway in rats

Neuropharmacology, 2020-07, Vol.171, p.108101-108101, Article 108101

2020

Link zum Volltext

Verfügbarkeit prüfen

Suppression of EZH2 inhibits TGF-β1-induced EMT in human retinal pigment epithelial cells

Experimental eye research, 2022-09, Vol.222, p.109158-109158, Article 109158

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.649

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

ThemaBiochemistry & Molecular Biology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.418)
Mit Volltextzugriff
(1.523)

Publikationsform

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.446)
Ezh2
(1.438)
Life Sciences & Biomedicine
(1.413)
Humans
(811)
Oncology
(627)
Animals
(352)
Female
(335)
Enhancer Of Zeste Homolog 2 Protein - Genetics
(321)
Cell Biology
(314)
Enhancer Of Zeste Homolog 2 Protein - Metabolism
(314)
Cell Line, Tumor
(313)
Epigenetics
(305)
Male
(296)
Gene Expression
(281)
Enhancer Of Zeste Homolog 2 Protein
(244)
Mice
(233)
Tumors
(222)
Cancer
(220)
Proteins
(204)
Cell Proliferation
(198)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Oncotarget
(92)
Cancers
(39)
Frontiers In Oncology
(35)
Cell Reports
(27)
Biomedicine & Pharmacotherapy
(25)
Epigenomics
(24)
Oncotargets And Therapy
(24)
Clinical Epigenetics
(23)
Journal Of Cellular And Molecular Medicine
(22)
Bmc Cancer
(16)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(35)
... seit 30 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

EZH2 inhibitors sensitize myeloma cell lines to panobinostat resulting in unique combinatorial transcriptomic changes

Serum EZH2 protein levels are decreased in people with multiple sclerosis: A pilot study

AML-137: Expression of Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Gene (EZH2) In Acute Myeloid Leukemia

AML-192: Enhancer of Zeste Homolog 2 (EZH2) in COVID-19-Positive Acute Myeloid Leukemia

LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII

EZH2 Promotes Glioma Cell Proliferation, Invasion, and Migration via Mir-142-3p/KCNQ1OT1/HMGB3 Axis : Running Title: EZH2 Promotes Glioma cell Malignant Behaviors

USP7 inhibits TIMP2 by up-regulating the expression of EZH2 to activate the NF-κB/PD-L1 axis to promote the development of cervical cancer

EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer

Attenuated Salmonella-delivered PD-1 siRNA enhances the antitumor effects of EZH2 inhibitors in colorectal cancer

Cross-species analyses unravel the complexity of H3K27me3 and H4K20me3 in the context of neural stem progenitor cells

2,2- dimethylbenzopyran derivatives containing pyridone structural fragments as selective dual-targeting inhibitors of HIF-1α and EZH2 for the treatment of lung cancer

EZH2: a novel target for cancer treatment

The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells

Novel insights of EZH2-mediated epigenetic modifications in degenerative musculoskeletal diseases

Telomere dysfunction alters intestinal stem cell dynamics to promote cancer

The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter

Enhancer of Zeste Homolog 2 Inhibition Induces HLA Class I Re-Expression in Merkel Cell Carcinoma

ABCL-211: Mutations at Codon 641 of Exon 16 of EZH2 in Circulating and Tumor DNA: A Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with the R-CHOP Regimen

EZH2-mediated development of therapeutic resistance in cancer

RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer

Identification and functional analysis of the hub Ferroptosis-Related gene EZH2 in diabetic kidney disease

Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498

EZH2 in normal and malignant hematopoiesis

Inhibition of EZH2 attenuates inhibitory synaptic transmission via the pro-inflammatory pathway in rats

Suppression of EZH2 inhibits TGF-β1-induced EMT in human retinal pigment epithelial cells

Aktive Filter

Suchergebnisse filtern